CNR2 and neoplasm: CB2 activation can produce beneficial outcomes via suppressing macrophage-mediated inflammatory pathways in animal models for various diseases that involve acute or chronic central or peripheral inflammation, whereas blocking CB2 may have utility when macrophage polarisation to a “resolving” phenotype is deleterious, such as in tumour-associated macrophages.